Julie Marsh
Julie is a PhD student in her final year within the Centre for Genetic Epidemiology & Biostatistics, following 10 years with Glaxo-Wellcome (UK) and a career break to raise a young family. Her PhD title is "The association of breast cancer susceptibility SNPs with antenatal and early childhood growth", for which she is working in collaboration with the ALSPAC (Bristol, UK) and Gen-R (Rotterdam, Netherlands) Study Teams.
She is supervised by Prof Lyle Palmer, Prof Michael Millward, Prof David Joseph, Prof George Davey-Smith and Prof Adrian Baddeley.
Julie's longer term breast cancer research concerns the role played by our genes in determining our response to radiotherapy, for which she is working in collaboration with Prof John Hopper and PI's from the National Cancer Institute (US) Breast Cancer Family Registry. In parallel she is working closely with Prof Jim Denham in the establishment of a prostate cancer genetic epidemiological resource linked to clinical trial data from the Trans-Tasman Radiation Oncology Group (TROG) and is a founder member of the Australian Genomics and Clinical Outcomes of Glioma (AGOG) team.
Julie is an AMBeR (Australia) and CAITE (UK) Scholar with research interests in:
- Genetic:environment associations in antenatal & early childhood growth (Development Origins of Health and Disease)
- Missing data methodology
- Genetic:environment associations in radiotherapy outcomes for the
treatment of cancer - Cancer pharmacogenetics
Qualifications
- 1989, BSc (Hons, first class) - Combined Studies (major statistics), University of Hertfordshire (Hatfield Polytechnic), UK.
- 1990, MSc - Medical Statistics, London School of Hygiene & Tropical Medicine, University of London, UK.
- 1994, CStat - Chartered Statistician, The Royal Statistical Society
Awards and Honours
- 1989, Glaxo Group Research MSc Scholarship
- 2006-present, War Widows' Guild of Western Australia PhD Scholarship, University of Western Australia
- 2006-present, Departmental Ad Hoc Top-up PhD Scholarship
)